AI Science Tracker

Structure-informed model selects antibody variants active against SARS-CoV-2 escape variants

Stanford University · 25 Jul 2024 · medicine

Discovery

Structure-informed model selects antibody variants active against SARS-CoV-2 escape variants

ESM-IF1 scored substitutions in antibody–antigen complexes, and researchers experimentally screened variants of two clinical antibodies. The journal article reports up to 25-fold neutralization improvement against BQ.1.1 and up to 37-fold affinity improvement against XBB.1.5; these are distinct assays/variants. The preprint abstract reports a different neutralization figure, so this record uses journal values and does not backdate them to preprint v1.

Technology: ESM-IF1 inverse-folding protein model

Family ESM / ESMFold: profile · models page

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: PMC-hosted primary article reports experimental screening and improved neutralization/affinity results for antibody variants.
  • Still unknown: Exact v1 result content and sequence-level overlap with earlier group studies not completely established; no clinical efficacy.
  • AI role: Structure-informed inverse-folding scores guided substitutions followed by antibody binding and neutralization tests.

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC11616794/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 16 Nov 2026. Review scope: Primary source checked for identity, date, model role and bounded reported result..

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open in the full catalog for filters, charts and related discoveries.